[New guideline on hypertension sickens society].
The introduction in the USA of the new AHA Guideline on management of Hypertension has fuelled controversy on the optimal definition and treatment of hypertension. A more strict definition (130/80 mmHg) and the advice to treat the major part of the hypertensive population well below 140/90 mmHg is a recipe for medicalisation of society. Advocates of the guideline emphasise the growing body of evidence to support more aggressive treatment. This evidence however seems to focus merely on the reduction of risk on cardiovascular disease or death. It does not, however, take into account at what costs. These costs are not limited to actual cost-effectiveness of implementation of the new guideline but stretch far beyond to involve also the actual and societal costs of medicalisation.